Amphetamine reinstates polydipsia induced by chronic exposure to quinpirole, a dopaminergic D2 agonist, in rats

Behavioural Brain Research

Volumn 89, Issue 1-2, 1997, Pages 199-215

  Fraioli, Sabina ^a   Cioli, Irene ^a   Nencini, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Amphetamine; Domperidone; Polydipsia; Quinpirole; Rats; SCH 23 390; SKF 38393

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; DOMPERIDONE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; QUINPIROLE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIURESIS; DRUG DISCRIMINATION; FLUID INTAKE; FOOD INTAKE; MALE; NONHUMAN; POLYDIPSIA; PRIORITY JOURNAL; RAT;

AMPHETAMINE; ANIMALS; DISCRIMINATION (PSYCHOLOGY); DIURESIS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DRINKING BEHAVIOR; EATING; MALE; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; URINATION;

EID: 0031413577     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)00063-6     Document Type: Article

References (55)

1. Änggård E., Gunne L.-M., Jönsson L.-E., Niklasson F. Pharmacokinetic and clinical studies on amphetamine dependent subjects. Europ. J. Clin. Pharmacol. 3:1970;3-11.
2. 1 receptor agonists combined with quinpirole facilitate the expression of oral stereotyped behaviour in rats. Eur. J. Pharmacol. 133:1987;137-145.
3. Badiani A., Stewart J. Amphetamine increases the speed of licking in the rat: sensitization after chronic intermittent treatment. Behav. Pharmacol. 4:1993;451.
4. Badiani A., Anagnostaras S.G., Robinson T.E. The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment. Psychopharmacology. 117:1995;443-452.
5. 1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area inejctions of D-amphetamine. J. Pharmacol. Exp. Ther. 277:1996;1177-1187.
6. 2 receptor interaction in the generation of dopamine agonist related behaviors. Eur. J. Pharmacol. 131:1986;301-306.
7. Camanni S., Nencini P. Physiological and environmental aspects of drinking stimulated by chronic exposure to amphetamine in rats. Gen. Pharmac. 25:1994;7-13.
8. Champion M.C. Domperidone, Gen. Pharmac. 19:1988;499-505.
9. Clifton P.G. Effects of SCH39166 and domperidone on the meal patterning of male rats. Pharmacol. Biochem. Behav. 52:1995;265-270.
10. 2 Dopamine Receptor Interactions. London: Academic Press, 1993:203-233.
11. 2 receptors. Psychopharmacology. 106:1992;447-454.
12. Einat H., Einat D., Allan M., Talangbayan H., Tsafnat T., Szechtman H. Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole. Psychopharmacology. 127:1996;95-101.
13. Ellison G. Stimulant-induced psychosis, the dopamine theory of schizophrenia and the habenula. Brain Res. Rev. 19:1994;223-239.
14. Fitzsimons, J.T. The Physiology of Thirst and Sodium Appetite. Cambridge:Cambridge University Press, 1979:422-438.
15. Goldman M.B., Luchins D.J., Robertson G.L. Mechanism of altered water metabolism in psychotic patients with polydipsia and hyponatremia. N. Engl. J. Med. 318:1988;399-403.
16. 2 receptor selective antagonists: electrophysiological and behavioral studies. Synapse. 17:1994;43-61.
17. Illowsky B.P., Kirch D.G. Polydipsia and hyponatremia in psychiatric patients. Am. J. Psychiatry. 145:1988;675-683.
18. 2 receptors in the ventrolateral striatum are involved in feeding behaviour in rats. Pharmacol. Biochem. Behav. 50:1995;152-161.
19. Kinon B.J., Lieberman J.A. Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology. 124:1996;2-34.
20. Koechling U., Colle L.M., Wise R.A. Effects of SCH 23390 on motivational aspects of deprivation-induced feeding. Psychobiology. 16:1988;207-212.
21. LeDuc P.A., Mittleman G. Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence. Psychopharmacology. 121:1995;407-427.
22. Lee M.R. Dopamine and the kidney: 10 years on. Clin. Sci. 84:1993;357-375.
23. 1 receptor: focus on negative symptoms. Prog. Neuropsychopharmacol. Biol. Psychiatry. 16:1992;797-832.
24. Lokhandwala M.F., Amenta F. Anatomical distribution and function of dopamine receptors in the kidney. FASEB J. 5:1991;3023-3030.
25. Mattingly B.C., Rowlett J.K., Lovell G. Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine. Psychopharmacology. 110:1993;320-326.
26. Mitchelson F. Pharmacological agents affecting emesis. A review (Part II). Drugs. 43:1992;443-463.
27. Mittelman G., Valenstein E.S. Individual difference in non-regulatory ingestive behavior and catecholamine system. Brain Res. 348:1985;112-117.
28. 2 receptor agonist: studies in conscious Brattelboro and Long-Evans Rats. J. Pharmacol. Exp. Ther. 242:1987;143-151.
29. Nagahata Y., Azumi Y., Kawakita N., Wada T., Saitoh Y. Inhibitory effect of dopamine on gastric motility in rats. Scand. J. Gastoenterol. 30:1995;880-885.
30. Neisewander J.L., Lucki I., McGonigle P. Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats. Pharmacol. Biochem. Behav. 52:1996;935-942.
31. Nencini P. The role of opiate mechanism in the development of tolerance to the anorectic effects of amphetamines. Pharmacol. Biochem. Behav. 30:1988;755-764.
32. Nencini P., Woolverton W.L. Effects of nimodipine, a calcium channel blocker, on the discriminative stimulus properties of D-amphetamine in rats. Psychopharmacology. 96:1988;40-44.
33. Nencini P., Fraioli S. Environment-specific reinstatement of amphetamine-mediated hyperdipsia by morphine and (-)-norpseudoephedrine. Pharmacol. Biochem. Behav. 47:1994;339-343.
34. Nencini P., Valeri P. The role of opioid mechanism in the anorectic effects of stimulants: U50,488H enhances amphetamine inhibition of free feeding in rats. Pharmacol. Biochem. Behav. 48:1994;63-68.
35. Nencini P., Valeri P., Morrone L.A. Dapiprazole, a selective alpha-1 adrenoceptor antagonist, inhibits diuresis but not polydipsia produced by amphetamine in rats. Brain Res. Bull. 25:1990;765-767.
36. 2 receptors in the development of amphetamine hyperdipsia. Soc. Neurosci. Abstr. 20(1):1994;585.
37. Nielsen E.B., Randrup K., Andersen P.H. Amphetamine discrimination: effects of dopamine receptor agonists. Europ. J. Pharmacol. 160:1989;252-262.
38. Phillips G.D., Howes S.R., Whitelaw R.B., Robbins T.W., Everitt B.J. Analysis of the effects of intra-accumbens SKF-38393 and LY-171555 upon behavioural satiety sequence. Psychpharmacology. 117:1995;82-90.
39. Poulos C.X., Cappell H. Homeostatic theory of drug tolerance: a general model of psychological adaptation. Psychol. Rev. 98:1991;390-408.
40. Raskind M.A., Weitzman R.E., Orenstein H., Fisher D.A., Courtney N. Is antidiuretic hormone elevated in psychosis? a pilot study. Biol. Psychiatry. 13:1978;382-390.
41. Renaud L.W., Bourque C.P. Neurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin and oxytocin. Prog. Neurobiol. 36:1991;131-169.
42. Robbins S.J., Ehrman R.N. Designing studies of drug conditioning in humans. Psychopharmacology. 106:1992;143-152.
43. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
44. Rowland N., Antelman S.M., Kocan D. Elevated water intake in rats treated cronically with amphetamine: drinking in excess of need? Appetite. 2:1981;51-66.
45. Rowlett J.K., Mattingly B.A., Bardo M.T. Repeated quinpirole treatment: locomotor activity, dopamine synthesis, and effects of selective dopamine antagonists. Synapse. 20:1995;209-216.
46. 2) receptor subtypes after chronic manipulation of dietary salt. Neurochem. Res. 20:1995;121-128.
47. Sharif N.A., Nunes J. L, Lake K.D., McClelland D.L., Corkins S.F. Lakatos, I, Rosenkranz, R.P., Whiting, R.L. and Eglen, R.M., Chronic manipulation of dietary salt modulates renal physiology and kidney dopamine receptor subtypes: functional and autoradiographic studies. Gen. Pharmac. 26:1995;727-735.
48. 2 dopamine receptors. J. Pharmacol. Exp. Ther. 265:1993;52-59.
49. Smith F.L., St.John C., Yang T.F.T., Lyness W.H. Role of specific dopamine receptor subtypes in amphetamine discrimination. Psychopharmacology. 97:1989;501-506.
50. Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmacol. 4:1993;289-312.
51. Stoof J.C., Kebabian J.W. Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci. 35:1984;2281-2296.
52. Terry, P., Dopamine receptor subtypes and ingestive behaviour. In Cooper, S.J. and Clifton, P.G. (Eds.) Drug receptor subtypes and ingestive behaviour, Academic Press, London 1996, pp. 233-266.
53. Vieweg W.V.R., David J.J., Rowe W.T., Peach M.J., Verhuis J.D., Kaiser D.L., Spradlin W.W. Psychogenic polydipsia and water intoxication - concepts that have failed. Biol. Psychiatry. 20:1985;1308-1320.
54. 2 antagonist raclopride. Synapse. 17:1994;155-159.
55. Zarrindast M.R., Owji A.A., Hosseini-Nia T. Evaluation of dopamine receptor involvement in rat feeding behaviour. Gen. Pharmac. 22:1991;1011-1016.